- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Risk Factors for Rapid Disease Progression of ADPKD
About This Event
Risk Factors for Rapid Disease Progression of ADPKD
In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of rapid disease progression will be discussed.
Jag’s Steak & Seafood (West Chester)
5980 West Chester Rd.
West Chester Township, Ohio 45069 United States + Google Map(513) 860-5353 View Venue WebsiteFeaturing
Jill A Green, PhD
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Medical Science Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts.
Rima Kang, MD
Assistant Professor of Clinical Medicine, Division of Nephrology at The Ohio State UniversityDr. Rima Kang is an Assistant Professor of Clinical Medicine, within the Division of Nephrology at The Ohio State University, in Columbus, Ohio. Dr. Kang is the lead nephrologist for cystic kidney diseases and was instrumental in developing a specialty clinic at The Ohio State University with an emphasis on ADPKD care.
Dr. Rima Kang is an Assistant Professor of Clinical Medicine, within the Division of Nephrology at The Ohio State University, in Columbus, Ohio. Dr. Kang received her medical degree from Northeast Ohio Medical University and completed her residency in Internal Medicine at the University of Cincinnati Medical Center. Dr. Kang then went on to complete a distinguished fellowship in Nephrology at The Ohio State University Wexner Medical Center.
Upon joining faculty at Ohio State, Dr. Kang has become the lead nephrologist in cystic kidney disease care and was instrumental in developing a specialty clinic at Ohio State with an emphasis in ADPKD and CKD care. Dr. Kang continues to advocate for improved patient care and is an active member in multiple associations and committees, including the National Kidney Foundation (NKF), the Internal Medicine Quality and Patient Safety Committee, and the Internal Medicine Diversity and Inclusion Committee.
Jill A. Green, PhD and Rima Kang, MD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
